Reporting owner · Q3 2026 · CIK 1665419

Arnold Frances: insider trades.

Arnold Frances reported 8 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($71K), across 2 companies.

Transactions
8
Purchases (P)
0
Sales (S)
3
Companies
2
Name as filed
ARNOLD FRANCES

Companies

CompanyRelationshipTransactions
Alphabet Inc. (GOOGL)Director7
Generate Biomedicines, Inc.Director1

Transactions

8 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-14Alphabet Inc.A11$0941Form 4
2026-09-14Alphabet Inc.A1$01,433Form 4
2026-09-14Alphabet Inc.A0$0597Form 4
2026-09-14Alphabet Inc.A1$0904Form 4
2026-09-01Generate Biomedicines, Inc.S1,000$16231,472Form 4
2026-08-28Alphabet Inc.S82$337.7118,995Form 4
2026-07-30Alphabet Inc.S82$333.3918,914Form 4
2026-07-01Alphabet Inc.A980$0980Form 4

Questions

What stock did Arnold Frances buy or sell?

Arnold Frances reported 8 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($71K), across 2 companies.

Is Arnold Frances the same person as other filers with this name?

This page covers SEC CIK 1665419 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/arnold-frances-1665419.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.